Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.23) by 34.78 percent. This is a 19.23 percent decrease over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $8.002 million which beat the analyst consensus estimate of $7.600 million by 5.29 percent. This is a 11.06 percent increase over sales of $7.205 million the same period last year.